DXR
DAXOR CORP
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$9.84
−2.09%Oct 1, 2026, 12:00 UTC
Daxor will showcase its FDA 510(k)-cleared next-generation Blood Volume Analyzer (BVA) and new clinical data at HFSA 2026 in Phoenix, Arizona, October 9-12, 2026.
Source:Jul 30, 2026, 02:40 UTC
Daxor Corporation launched a new outpatient Blood Volume Analysis program at a healthcare facility in eastern Kansas.
Source:Jun 2, 2026, 12:00 UTC
Daxor Corporation received a U.S. patent for its remote blood volume monitor, enabling continuous tracking of blood volume status via wearable sensors.
Source: